Carna Biosciences, Inc. (4572)(製薬・医療分野):企業M&A動向

◆英語タイトル:Carna Biosciences, Inc. (4572) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:GDPH82659D
◆発行会社(調査会社):GlobalData
◆発行日:2015年3月13日
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥26,750見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD500 ⇒換算¥53,500見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD750 ⇒換算¥80,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary

Carna Biosciences, Inc. is a biotechnology company. The company discovers and develops drugs for the treatment of patients with cancer and anti-inflammatory diseases by using QuickScout, which is a kinase drug discovery platform. Carna Biosciences’ products and services include kinase proteins, biotinylated kinases, profiling services, RPPA cell signaling analysis service, live-cell kinase assays, claricell kinase cell-based assay services, crystallography, assay development and substrates. Carna Biosciences provides a range of protein kinases, which include cytoplasmic tyrosine kinase, receptor tyrosine kinase and ser and threonine kinases. The company’s profiling services include pre-selected panels, service flow, application form, samples shipping instructions and yearly schedule of services. The company’s subsidiaries include Kinase Logistics ApS, Shanghai Universal Biotech Company, Biogenuix Medsystems Pvt. Ltd., CarnaBio USA, Inc., and EUROMEDEX. Carna Biosciences is headquartered in Kobe, Japan.

Carna Biosciences, Inc. (4572) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Carna Biosciences, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015 5
Carna Biosciences, Inc., Pharmaceuticals & Healthcare Deals By Type, 2009 to YTD 2015 6
Carna Biosciences, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2009 to YTD 2015 7
Carna Biosciences, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2009 to YTD 2015 8
Carna Biosciences, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2009 to YTD 2015 9
Carna Biosciences, Inc., Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Netherlands Translational Research Center Enters Into Co-Marketing Agreement With Carna Biosciences 10
TCG Lifesciences Enters Into Strategic Alliance With Carna Biosciences 11
Equity Offering 12
Carna Biosciences Completes Private Placement Of US$0.26 Million 12
Carna Biosciences Completes Public Offering Of US$3.49 Million 13
Acquisition 14
Carna Biosciences Announces Stock Exchange Ratio To Acquire ProbeX 14
Carna Biosciences, Inc. – Key Competitors 15
Key Employees 16
Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Carna Biosciences, Inc., Pharmaceuticals & Healthcare, Key Facts, 2014 1
Carna Biosciences, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015 5
Carna Biosciences, Inc., Pharmaceuticals & Healthcare Deals By Type, 2009 to YTD 2015 6
Carna Biosciences, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2009 to YTD 2015 7
Carna Biosciences, Inc., Deals By Therapy Area, 2009 to YTD 2015 8
Carna Biosciences, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2009 to YTD 2015 9
Netherlands Translational Research Center Enters Into Co-Marketing Agreement With Carna Biosciences 10
TCG Lifesciences Enters Into Strategic Alliance With Carna Biosciences 11
Carna Biosciences Completes Private Placement Of US$0.26 Million 12
Carna Biosciences Completes Public Offering Of US$3.49 Million 13
Carna Biosciences Announces Stock Exchange Ratio To Acquire ProbeX 14
Carna Biosciences, Inc., Key Competitors 15
Carna Biosciences, Inc., Key Employees 16
Carna Biosciences, Inc., Subsidiaries 17

List of Figures
Carna Biosciences, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2009 to YTD 2015 1
Carna Biosciences, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015 1
Carna Biosciences, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2009 to YTD 2015 1
Carna Biosciences, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2009 to YTD 2015 1
Carna Biosciences, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015 5
Carna Biosciences, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2009 to YTD 2015 6
Carna Biosciences, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2009 to YTD 2015 7
Carna Biosciences, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2009 to YTD 2015 8

★海外企業調査レポート[Carna Biosciences, Inc. (4572)(製薬・医療分野):企業M&A動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Renewable Energy Holdings plc (REH):企業のM&A・提携動向(発電分野)
    Summary Renewable Energy Holdings plc (REH) is a renewable energy company that operates wind assets. The company carries out activities such as development of green-field project opportunities; acquisition of operating assets with upside potential; and acquisition of late stage project development o …
  • Ondine Biomedical Inc.:(医療機器分野)企業M&A及び提携動向
    Summary Ondine Biomedical Inc. (Ondine), formerly known as Ondine Biopharma Corporation, is a biotechnology company. The company develops non-antibiotic, anti-infective therapies for bacterial, viral and fungal infections. It concentrates on the development and commercialization of photodisinfection …
  • Corning Incorporated:企業のM&A・事業提携・投資動向
    Corning Incorporated - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Corning Incorporated Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Celonic GmbH(製薬・医療分野):企業M&A動向
    Summary Celonic GmbH (Celonic) is a biotechnology company. The company provides contract manufacturing and analytics services for biopharmaceutical companies. Its services include the cell-line development, process development, GMP production, GMP analytics and quality control, and GLP and GCP analy …
  • World Fuel Services Corporation:企業のM&A・提携・投資分析
    World Fuel Services Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's World Fuel Services Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers …
  • Anite plcの企業概要及び財務/SWOT分析
    Anite plc Fundamental Company Report provides a complete overview of the company’s affairs. The report includes financial and SWOT information, industry analysis, opinions, estimates, Anite plc annual and quarterly forecasts made by stock market experts. The report also enables direct comparison to …
  • WandT Offshore, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' WandT Offshore, Inc. Mergers an …
  • PT Dynaplast Tbkの企業概要及び財務/SWOT分析
    PT Dynaplast Tbk Fundamental Company Report provides a complete overview of the company’s affairs. The report includes financial and SWOT information, industry analysis, opinions, estimates, PT Dynaplast Tbk annual and quarterly forecasts made by stock market experts. The report also enables direct …
  • Dillard’s, Inc.:企業の戦略・SWOT・財務分析
    SummaryDillard's, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Finding …
  • AMETEK Inc (AME)-医療機器分野:企業M&A・提携分析
    Summary AMETEK Inc (AMETEK) is an electronic products manufacturing company that manufactures electronic instruments and electromechanical devices. The company's products include medical materials, motion control systems, sub assemblies and connectors, electrical cord reels, gauges, titanium alloys …
  • Myriad Genetics Inc (MYGN):企業の製品パイプライン分析2018
    Summary Myriad Genetics Inc (Myriad) is a specialty molecular diagnostic company, which discovers and commercializes molecular diagnostic tests, personalized medicine and services for major diseases. The company’s product portfolio includes molecular diagnostic testing products that analyze genes, t …
  • Berkeley Energy Limited (BKY):企業概要およびSWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "Berkeley Energy Limited" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetric strictly f …
  • OSRAM Licht AG:企業のM&A・事業提携・投資動向
    OSRAM Licht AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's OSRAM Licht AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Phylogica Ltd (PYC):企業財務及び戦略的SWOT分析
    Summary Phylogica Ltd (Phylogica) is a biotechnology company that provides peptide drug discovery services to the pharmaceutical industry. The company’s products include libraries and peptides. Its Phylomer libraries are in variety of phage display and yeast-two-hybrid formats and in mammalian expre …
  • EnerTeck Corporation (ETCK):企業財務及び戦略的SWOT分析
    Summary EnerTeck Corporation (EnerTeck) formerly Gold Bond Resources, Inc., is a combustion enhancement technology provider that provides advanced engine treatment application technology and fuel management systems. The company’s products include EnerBurn, a diesel fuel specific combustion catalyst; …
  • Sawai Pharmaceutical Co., Ltd. (4555)(製薬・医療分野):企業M&A動向
    Summary Sawai Pharmaceutical Co., Ltd. (Sawai Pharmaceutical) is a pharmaceutical company. The company manufactures, sells, imports and exports pharmaceutical products. Its products include cardiovascular drugs, antihyperlipidemic agents, diabetes drugs, anticancer drugs, and OTC drugs. Sawai Pharma …
  • Pernix Therapeutics Holdings, Inc. (PTX):企業概要、財務及び戦略的SWOT分析
    Summary Pernix Therapeutics Holdings, Inc. (Pernix Therapeutics) is a pharmaceutical company. The company develops, markets and sells generic pharmaceutical products for the pediatric market. Its pediatric products include Silenor, CEDAX CEFTIBUTEN, Natroba, Rezyst IM Probiotic and Rezyst SB Probiot …
  • Host Hotels & Resorts, Inc.:企業の戦略・SWOT・財務情報
    Host Hotels & Resorts, Inc. - Strategy, SWOT and Corporate Finance Report Summary Host Hotels & Resorts, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • F-star Biotechnology Ltd-製薬・医療分野:企業M&A・提携分析
    Summary F-star Biotechnology Ltd (F-star) is a drug development company that offers novel bispecific antibodies. The company develops immuno-oncology bispecific antibody therapeutics. Its technologies comprise modular antibody technology, a proprietary engine that generates bispecific antibodies; mA …
  • Benihana Inc.:企業の戦略・SWOT・財務分析
    Benihana Inc. - Strategy, SWOT and Corporate Finance Report Summary Benihana Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆